📰 Morphosys Daily News
Morphosys Daily News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Morphosys Daily. Real-time updates on events, politics, business and more.
May 26, 2024
MorphoSys (NASDAQ:MOR – Get Free Report) is scheduled to be releasing its earnings data before the market opens on Monday, May 27th. Analysts expect MorphoSys to post earnings of ($1.30) per share for the quarter. MorphoSys (NASDAQ:MOR – Get Free Report) last released its earnings results on Monday, April 29th. The company reported ($2.24) earnings […]
May 26, 2024
MorphoSys (NASDAQ:MOR – Get Free Report) will release its earnings data before the market opens on Monday, May 27th. Analysts expect MorphoSys to post earnings of ($1.30) per share for the quarter. MorphoSys (NASDAQ:MOR – Get Free Report) last posted its quarterly earnings data on Monday, April 29th. The company reported ($2.24) EPS for the […]
May 26, 2024
MorphoSys (NASDAQ:MOR – Get Free Report) will be issuing its quarterly earnings data before the market opens on Monday, May 27th. Analysts expect the company to announce earnings of ($1.30) per share for the quarter. MorphoSys (NASDAQ:MOR – Get Free Report) last posted its earnings results on Monday, April 29th. The company reported ($2.24) earnings […]
May 22, 2024
MorphoSys (NASDAQ:MOR – Get Free Report) and Graybug Vision (NASDAQ:GRAY – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, risk, institutional ownership, earnings, dividends and analyst recommendations. Valuation & Earnings This table compares MorphoSys and Graybug […]
May 22, 2024
MorphoSys AG (NASDAQ:MOR – Get Free Report) has received a consensus recommendation of “Hold” from the eight ratings firms that are presently covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price objective among […]
April 1, 2024
MorphoSys (OTCMKTS:MPSYF – Get Free Report) and BioRestorative Therapies (OTCMKTS:BRTX – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk and analyst recommendations. Insider and Institutional Ownership 69.4% of BioRestorative Therapies shares […]
February 8, 2024
Wells Fargo & Company reaffirmed their overweight rating on shares of MorphoSys (NASDAQ:MOR – Free Report) in a report issued on Monday, Benzinga reports. They currently have a $17.00 price objective on the stock. Several other analysts also recently commented on MOR. Leerink Partnrs restated a market perform rating on shares of MorphoSys in a […]
February 6, 2024
Shares of MorphoSys AG (NASDAQ:MOR – Get Free Report) traded down 6% during trading on Tuesday . The stock traded as low as $15.97 and last traded at $16.23. 17,579,874 shares were traded during trading, an increase of 527% from the average session volume of 2,805,517 shares. The stock had previously closed at $17.27. Analyst […]
February 2, 2024
MorphoSys AG (NASDAQ:MOR – Free Report) – Leerink Partnrs issued their Q1 2024 earnings estimates for MorphoSys in a report released on Tuesday, January 30th. Leerink Partnrs analyst A. Berens anticipates that the company will post earnings per share of ($0.65) for the quarter. Leerink Partnrs currently has a “Market Perform” rating on the stock. […]
January 27, 2024
MorphoSys AG (NASDAQ:MOR – Get Free Report)’s share price gapped up prior to trading on Wednesday . The stock had previously closed at $9.12, but opened at $9.63. MorphoSys shares last traded at $9.66, with a volume of 80,068 shares changing hands. Analysts Set New Price Targets A number of brokerages have recently issued reports […]